Abstract
Grading of Neurotoxicity in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL) Receiving Tisagenlecleucel Treatment in the JULIET Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have